Patents Examined by Carol Ann Chase
  • Humanized anti-CD45 antibodies
    Patent number: 11981741
    Abstract: Provided are humanized anti-human CD45 antibodies and pharmaceutical compositions including the antibodies.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: May 14, 2024
    Assignee: Actinium Pharmaceuticals, Inc.
    Inventors: Lequn Zhao, Helen Kotanides
  • Anti-HER3 humanized monoclonal antibody
    Patent number: 11965037
    Abstract: Provided is an anti-HER3 humanized monoclonal antibody. The antibody binds HER3 antigen, has high affinity and biological activity and low immunogenicity, and is stable in structure. The antibody can be used for preparing drugs for preventing or treating HER3-related diseases.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: April 23, 2024
    Assignee: SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
    Inventors: Aidong Qu, Hongyuan Liang, Fanhong Xu, Aoxiang Li, Lina Wu, Jingye Zhu, Jianhua Qiu, Jin Lu, Lin Zhang, Xin Zhao, Xiaofei Song